Dimerix Share Price and Company Fundamentals

-0.005 (-1.887%)
52 week
0.195 - 0.48

Last traded: Last Friday at 5:10 AM

Dimerix Limited, a clinical-stage biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs. The company develops DMX-200 that is in two Phase 3 clinical trials for COVID respiratory complications; DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; and DMX-700 that is in pre-clinical development for chronic obstructive pulmonary disease. The company was founded in 2004 and is headquartered in Fitzroy, Australia.

Key Metrics

PE ratio


PB ratio


Dividend yield



Market cap


Enterprise value


Company profile

Primary activitiesA Clinical stage (Phase II) biotechnology business commercialising new therapies for under-served and unmet medical needs globally
Industry / SectorBiotechnology / Healthcare
Mailing address425 Smith Street Fitzroy VIC 3065 Australia
Phone / Fax61 3 0081 3321 /


Dimerix does not pay dividends.

Company Executives

As of Jan 2022, following are the company executives and directors listed on Dimerix.

NameTitleAgeTotal Pay
Dr. Nina Webster B.Sc., M.B.A., M.IP.Law, MBA, Ph.D.CEO, MD & Director373.45k
Mr. Hamish George B.Com., C.A.CFO & Company Sec.
Mr. Kevin Donald George Pfleger BA (Hons), MA, Ph.D.Chief Scientific Advisor
Ms. Elizabeth McCall B.Com(Hons), B.Juris, BJURIS, GAICD, L.L.B., LLB.Bus. Devel. Officer

Profitability and management effectiveness

Profit margin


Operating margin


Return on assets


Return on equity


Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Dimerix is and its enterprise value is .

The DXB's stocks Beta value is 0.98 making it 2% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Dimerix (DXB)

Dimerix (ASX:DXB) Frequently Asked Questions

1. What is Dimerix's Stock Symbol?

Dimerix trades on ASX under the ticker symbol "DXB".

2. What is Dimerix's stock price today?

One share of DXB stock can currently be purchased for approximately $0.26.

3. How can I contact Dimerix?

Dimerix's mailing address is 425 Smith Street Fitzroy VIC 3065 Australia. The company can be reached via phone at 61 3 0081 3321.

4. What is Dimerix's official website?

The official website of Dimerix is https://dimerix.com.

5. Which share registry manages Dimerix's stock?

Dimerix's stock is managed by AUTOMIC REGISTRY SERVICES.